PFE
NYSEPFIZER INC
Health Care, Pharmaceuticals
$26.76
close 7 Aug 2026
+8.87%
52-week change
$152.52B
market cap
$23.58
$28.75
52-week range
Valuation
Market cap$152.52B
P/E (TTM / 5y avg)35.21x18.49x
Forward P/E (FY2026 / FY2027)9.01x9.29x
PEG (TTM / fwd)——
P/S (TTM)2.39x
P/B1.79x
EV/EBITDA (TTM)15.96x
FCF yield (TTM)7.20%
Cash flow & dividend
FCF (TTM)$10.99B
FCF per share (TTM)$1.93
FCF margin (TTM)17.25%
Dividend yield (indicated / 5y avg)6.43%5.19%
Annualized dividend$1.72
Payout ratio (EPS / FCF)225.83%89.08%
Growth & quality
Revenue YoY, latest Q+2.60%
Diluted EPS YoY, latest Q-107.84%
Operating margin (TTM)—
Net margin (TTM)6.80%
ROE (latest FY)8.99%
Net debt / EBITDA (TTM)4.62
Interest coverage (TTM)—
Price
-44.80%-11.24%/yrover 5y
Weekly closes · split-adjusted
close 7 Aug 2026
Fundamentals
Fiscal years, last 10, CAGR chips on growth series, plus a dimmed trailing-twelve-month bar
Revenue
5Y CAGR +8.48%10Y CAGR +2.51%
Diluted EPS
5Y CAGR -3.56%10Y CAGR +2.59%
FCF per share
5Y CAGR -6.03%10Y CAGR -2.33%
Operating cash flow
5Y CAGR -4.07%10Y CAGR -2.25%
Free cash flow
5Y CAGR -5.71%10Y CAGR -3.74%
Dividends per share
5Y CAGR +2.63%10Y CAGR +5%
Payout ratio
FCF payout ratio
FCF margin
Return on equity
Shares outstanding
5Y CAGR +0.34%10Y CAGR -1.44%
Net debt / EBITDA
Earnings
Street estimates, not SEC filings
Next / Q3 FY26
Date2 Nov 2026
EPS estimate$0.8464
Revenue estimate$16.31B
Last reported
Date—
EPS——
Revenue——